In studies with OXYZYME, 71% of 12 week wounds or longer healed or improved in 6 weeks.
The management of chronic wounds in the UK has been estimated to cost over £1 billion a year (Bennett et al 2004), with an additional cost to patients of reduced quality of life (Charles 2004). More than 40 per cent of ulcers are unhealed at 20 weeks and more than 20 per cent still unhealed at 70 weeks (Rippon et al 2006).
Meta-analysis of the extensive case study programme featuring wounds of different aetiologies and age indicates an outstanding clinical response to the use of OXYZYME.
All wounds were of 12 weeks duration or longer, with compression if indicated. The previous treatment regime was known in 85% of cases, and featured most commonly prescribed modern wound dressings.
Overall, (n=107) healed/improved was 71% at 6 weeks, of which, over 1/3rd of the improved wounds had reduced in area by more than 50%.
Venous leg ulcer, (n=43) healed/improved was 75% at 6 weeks, with the proportion of healed wounds increasing from 21% to 28% if taken past 6 weeks.
Diabetic foot ulcers, (n=13) healed/improved was 77% at 6 weeks, with previous dressing regimes including Aquacel, Aquacel Ag, Biatain, Mepilex, Versiva XC, Honey, and VAC.
(All brands are trademarks of their respective owners)
Arterial ulcers, (n=15) healed/improved was 73% at 6 weeks.
Other chronic wounds, (n=10) healed/improved was 40% at 6 weeks, with wound aetiologies including EB, radionecrosis, radiotherapy, surgical, and sickle cell ulcer.
Pressure ulcers, (n=13) healed/improved was 69% at 6 weeks.
Mixed aetiology ulcers, (n=8) healed/improved was 76% at 6 weeks.
Wounds switched from foam dressings (n=23), healed/improved was 70% at 6 weeks.
Wounds switched from alginate/AquacelTM dressings (n=24), healed/improved was 71% at 6 weeks.
